HC Wainwright Initiates Autolus Therapeutics Coverage With Buy Rating
Benzinga reports HC Wainwright & Co. assumed coverage of Autolus Therapeutics with a Buy rating and announced a $10.00-per-share price target.
Related stories
Cencosud Closes Four Easy Stores in Chile
Cencosud closed four stores in its Easy chain: two in regional areas and two in Santiago.
L impact | EQUITY | Nov 02, 2026, 03:42 PM UTC
Greece Agrees to Acquire Up to Six Embraer KC-390 Jets
Greece agreed to acquire up to six KC-390 Millennium jets from Embraer.
M impact | EQUITY | Nov 02, 2026, 03:41 PM UTC
Cipher Digital Shares Fall After Third-Quarter Revenue Miss
Cipher Digital shares fell Monday morning after the company reported third-quarter revenue below estimates. Bitcoin mining remained the majority of revenue.
M impact | EQUITY | Nov 02, 2026, 03:41 PM UTC
Enerjisa Enerji reports Q3 revenue
Revenue was lower than in the same period last year.
M impact | EQUITY | Nov 02, 2026, 03:40 PM UTC
Enerjisa Enerji Reports Q3 Revenue of 75.8 Billion Lira
Q3 revenue was 75.8 billion lira, versus 78.8 billion lira a year earlier.
M impact | EQUITY | Nov 02, 2026, 03:40 PM UTC
Reliance Rally and LTCG Rollback Proposal Lift Indian Stocks Nearly 2%
Reliance Industries shares had their best day since 2020, while optimism about a possible rollback of long-term capital gains tax for foreign investors accompanied gains of nearly
M impact | EQUITY | Nov 02, 2026, 03:40 PM UTC